Articles from Biotech Business (September 1, 2009)

Title	Author	Type	Words
ADVANCED LIFE SCIENCES GETS LETTER FROM FDA FOR RESTANZA.			1021
FDA APPROVES AVASTIN FOR THE MOST COMMON KIDNEY CANCER.			798
FDA LIFTS PARTIAL CLINICAL HOLD OF ICA-105665.			562
PROJECT ZERO DELAY ACCELERATES DRUG'S PATH TO CLINICALTRIAL.			817